DOUGLAS E. WILLIAMS - 17 May 2021 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Doug Williams by PoA
Issuer symbol
OVID
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 21:04:25 UTC
Next filing
21 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +1,750 $0.000000 1,750 17 May 2021 Common Stock 1,750 $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.